Autologous Mesenchymal Stem Cells Transplantation in Thoracolumbar Chronic and Complete Spinal Cord Injury Spinal Cord Injury

About this trial

This is a clinical trial enrolling individuals with chronic complete spinal cord injuries in the thoracic (chest) and lumbar (lower back) areas to test the safety and effect of a stem cell injection. This study uses cells collected from each participant’s own bone marrow. If included in the study, participants will be randomly assigned to one of two groups receiving: 1) stem cells (treatment group), or 2) no stem cells (control group). Participants in the treatment group will receive two injections of stem cells over 3 months. Both treatment and control groups will be assessed for safety, functional improvement and nerve pain over 12 months.